Zou Xiaoming
邹晓明
CEO, Visirna
维亚臻CEO
Dr. Zou was appointed Chief Executive Officer of Visirna in January 2023. Before joining Visirna, he was Chief Executive Officer of EOC Pharma and Chief Business Officer of Eddingpharm. Dr. Zou also served as Executive Director of Licensing at Amgen, and was the External R&D Director at GSK. His responsibilities included product licensing and R&D collaboration in immunology, oncology, and CNS.
Dr. Zou completed his Ph.D. in Molecular Biophysics and Biochemistry at Columbia University. He also holds MS and BS degrees from Tsinghua University.
邹晓明博士拥有20多年国际医药领域行业经验。邹博士在创新药的产品引进、技术转让、资产并购、药物合作研究及商业化合作各领域持续深入关注并主导达成了一系列重大项目交易。
邹博士现任维亚臻（Visirna）的首席执行官，负责公司的战略制定和全面运营管理。此前，邹博士曾供职于亿腾医药集团，先后担任亿腾医药（Eddingpharm）的首席商务官（CBO）和亿腾景昂（EOC Pharma）的首席执行官（CEO），主要负责：亿腾景昂的战略制定以及运营管理；亿腾医药的商业拓展以及具有差异化竞争优势的产品线布局。在回到中国市场之前，邹博士曾供职于安进（Amgen）担任产品引进执行总监（Executive Director, Licensing）、和葛兰素史克（GSK）担任外部药物研发总监（Director，External R&D），主要负责免疫及抗肿瘤药物的技术研发、成果转化及引进。
邹博士拥有美国哥伦比亚大学分子生物物理学和生物化学专业博士学位，清华大学硕士及学士学位。
